Senti Biosciences Holdings, Inc. (SNTI) AI Dilution Summary

Estimated cash was $2,085,143 as of 2026-09-03, from $6,463,000 at 2026-06-30 against estimated monthly burn of $4,749,667. Funding runs through the active Leerink Partners LLC ATM, authorised to $17,500,000, with 4,833,477 shares sold since the program began through 2026-06-30; sales after 2026-06-30 are not yet reported. Additional Senior Secured Convertible Notes were issued after that date: $3,900,000 net on 2026-08-14 and $1,900,000 net on 2026-09-03.